Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06445192 · ClinicalTrials.gov registry record · NA

Evaluating the Impact of a Virtually Supervised Exercise Intervention and Group Counseling on Inflammation and the Microbiome of Smokers at High Risk for Lung Cancer, BE FIT Trial

A NA study of Lung Carcinoma, sponsored by Ohio State University Comprehensive Cancer Center.

Active
Registry status
NA
Development phase
65
Enrollment target
1
Study location

NCT06445192: Active NA study of Lung Carcinoma, sponsored by Ohio State University Comprehensive Cancer Center.

NCT06445192 is a NA study of Lung Carcinoma that is active but no longer recruiting, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 65 participants, below the 5,042-participant average among 38 other Lung Carcinoma trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06445192, a NA study of Lung Carcinoma, is active but no longer recruiting, sponsored by Ohio State University Comprehensive Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
65 participants
Enrollment target
1
Study location

Study Summary

This phase II trial evaluates how a virtually supervised exercise intervention in combination with group counseling affects inflammation and the bacterial composition (microbiome) of the gut in smokers who are at high risk for lung cancer. Physical exercise has been shown to reduce lung cancer development and to have beneficial effects on the gut microbiome and inflammation. Group counseling may promote adherence to the exercise intervention by empowering participants to exert greater control over their behavior and environment. This clinical trial may help researchers understand how exercise impacts inflammation and the microbiome in people at risk for lung cancer and whether or not exercise with counseling can improve health outcomes in high-risk individuals.

Primary Outcome

To evaluate the feasibility and preliminary efficacy of establishing a multi-component virtually-delivered exercise intervention trial with longitudinal biomarker and microbiome collection in the Ohio State University Lung Cancer Screening Clinic (OSULCSC)

Conditions Studied

Interventions

  • PROCEDURE Biospecimen Collection
  • OTHER Exercise Intervention
  • OTHER Medical Device Usage and Evaluation
  • OTHER Best Practice
  • OTHER Exercise Counseling

Study Locations (1)

Ohio

  • Ohio State University Comprehensive Cancer Center - Columbus

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2023-11-03
Est. Completion 2026-12-31
Phase NA

What the registry record for NCT06445192 still lists

NCT06445192 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 65 participants, a relatively small participant target, below the 5,042-participant average among 38 other Lung Carcinoma trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Lung Carcinoma appearing as the primary indexed condition, and to 5 interventions - of which Biospecimen Collection is the first listed.

NCT06445192 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT06445192 about?

NCT06445192 is a clinical study titled "Evaluating the Impact of a Virtually Supervised Exercise Intervention and Group Counseling on Inflammation and the Microbiome of Smokers at High Risk for Lung Cancer, BE FIT Trial". This phase II trial evaluates how a virtually supervised exercise intervention in combination with group counseling affects inflammation and the bacterial composition (microbiome) of the gut in smokers who are at high risk for lung cancer. Physical exercise has been shown to reduce lung cancer devel...

What is the current status of trial NCT06445192?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 65 participants. The study started on 2023-11-03. Estimated completion is 2026-12-31.

What conditions does trial NCT06445192 study?

This clinical trial studies the following conditions: Lung Carcinoma.

What interventions are being tested in trial NCT06445192?

The interventions under investigation include: Biospecimen Collection (PROCEDURE), Exercise Intervention (OTHER), Medical Device Usage and Evaluation (OTHER), Best Practice (OTHER), Exercise Counseling (OTHER).

Who is sponsoring clinical trial NCT06445192?

This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06445192 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06445192's enrollment target sits among peer trials

65 24th of 38 higher than 15 of 38 other Lung Carcinoma trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Lung Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03366116 · 65 participants · Phase 1

    5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors

  • NCT03603730 · 65 participants · NA

    Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis

  • NCT03796559 · 65 participants · NA

    Magseed Enabled Long-Term Localization of Axillary Lymph Nodes

  • NCT03993106 · 65 participants · Phase 2

    A Study of sEphB4-HSA in Kaposi Sarcoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06445192, the US trial registry maintained by the National Library of Medicine. NCT06445192 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.